In Vitro Efficacy of Ceftazidime-avibactam Against blaOXA-48-producing Klebsiella pneumoniae Isolates
Introduction: The healthcare burden of carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae) infections is growing. The newly developed beta-lactam/beta-lactamase inhibitor combination, ceftazidime-avibactam, shows promise in the treatment of such infections. We aimed to explore the in vitro ef...
Main Authors: | Yasemin ÇAĞ, Mücahide Esra KOÇOĞLU, Hülya ÇAŞKURLU, Demet HACISEYİTOĞLU, Hasan Cenk MİRZA, Aylin ÜSKÜDAR GÜÇLÜ, Rıza Aytaç ÇETİNKAYA, Haluk VAHABOĞLU |
---|---|
Format: | Article |
Language: | Turkish |
Published: |
Galenos Yayinevi
2023-11-01
|
Series: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
Subjects: | |
Online Access: | https://mjima.org/text.php?&id=391 |
Similar Items
-
The <i>Klebsiella pneumoniae</i> carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam
by: Sona Garsevanyan, et al.
Published: (2023-12-01) -
Clinical distribution of carbapenem genotypes and resistance to ceftazidime-avibactam in Enterobacteriaceae bacteria
by: Xueyun Zhu, et al.
Published: (2024-03-01) -
In vitro effectiveness of ceftazidime-avibactam in combination with aztreonam on carbapenemase-producing Enterobacterales
by: Papa-Ezdra Romina, et al.
Published: (2023-12-01) -
The Impact Of Ceftazidime-Avibactam Utilization In Hospital Setting
by: Shobana Selvaganesan, et al.
Published: (2024-12-01) -
Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an OXA-48 endemic area
by: Şevval Arduç Tok, et al.
Published: (2024-12-01)